LDS/Medical Tests/Aldosterone/Renin Activity Ratio

Aldosterone/Renin Activity Ratio

Renin is a serine protease that plays a role in maintaining blood pressure through it’s production of angiotensin I and ultimately the control of aldosterone production. Renin is produced by the juxtaglomerular cells in the kidney in response to decreased blood pressure and/or decreased sodium levels. Renin converts circulating angiotensinogen to angiotensin I, which is then converted to angiotensin II by endothelial cells (primarily in the lungs) via the action of Angiotensin Converting Enzyme (ACE). Angiotensin II is a potent vasoconstrictor and results in increased arterial pressure. Angiotensin II also stimulates the adrenal cortex to produce the hormone aldosterone. Aldosterone plays an important role in maintaining normal sodium and potassium concentrations in blood and thereby synergistically functions to increase blood volume and blood pressure. In assessing the Renin-Angiotensin System (RAS) plasma renin activity is measured along with the plasma aldosterone. The ratio of plasma aldosterone concentration to plasma renin activity has a sensitivity >95% in detecting primary aldosteronism. However, because the ratio has low specificity, uncontrolled aldosterone production must typically be confirmed by an aldosterone suppression test, typically based on either saline infusion or a high salt diet.

Renin activity may be increased in hyperaldosteronism, renal artery stenosis, chronic renal failure, nephrotic syndrome, congestive heart failure with left ventricular hypertrophy, adrenal insufficiency and water loss or dehydration. Decreased renin levels may be seen in hypoaldosteronism and with some drugs, such as diuretics and beta blockers that impact the RAS.

Primary aldosteronism is characterized by high plasma aldosterone levels and manifested by hypertension. High aldosterone levels are usually resistant and cannot be suppressed by sodium loading. Additionally, patients may have low plasma renin activity, an increased serum sodium level, and, in more severe cases, a decreased serum potassium levels. Underlying causes include adrenal adenoma, unilateral or bilateral adrenal hyperplasia, inherited hypertension syndromes, and rarely, adrenal carcinoma. The Endocrine Society recommends screening of high-risk hypertensive patients using the aldosterone to renin ratio for diagnosis of primary aldosteronism. The ratio is more sensitive than measuring potassium alone, and aldosterone measurements are more specific than renin measurements. If the ratio is elevated, 1 of 4 tests can be used to confirm the diagnosis: oral sodium loading, saline infusion, fludrocortisone suppression, or a captopril challenge.

  • Evaluation of patients with hypertension
  • Diagnosis of primary aldosteronism
  • As an aid in diagnosis of nephrotic syndrome
  • As an aid in diagnosis of congestive heart failure

Increased in:

  • Hyperaldosteronism
  • Dehydration
  • Renal artery stenosis
  • Edematous states such as in cirrhosis
  • Nephrotic syndrome and congestive heart failure (CHF)
  • Increased in some hypokalemic states such as gastrointestinal sodium and potassium loss
  • Adrenal insufficiency
  • Chronic renal failure
  • Left ventricular hypertrophy

Decreased in:

  • Hyporeninemic hypoaldosteronism
  • Some hypertensive states such as primary aldosteronism and preeclampsia
  • Also some drugs such as beta blockers, diuretics, aspirin, methyldopa, indomethicin
Population Posture / Timing Reference Range
Adult Upright 8:00-10:00 A.M. ≤28 ng/dL
Upright 4:00-6:00 P.M. ≤21 ng/dL
Supine 8:00-10:00 A.M. 3-16 ng/dL

 

Age Group Reference Range
1-12 Months 2-70 ng/dL
1-4 Years 2-37 ng/dL
5-9 Years ≤9 ng/dL
10-13 Years ≤21 ng/dL
14-17 Years ≤35 ng/dL

 

Infant Group Reference Range
Premature (31-35 Weeks) ≤144 ng/dL
Term ≤217 ng/dL

 

Tanner Stage Sex Reference Range
II-III Males 1-13 ng/dL
Females 2-20 ng/dL
IV-V Males 3-14 ng/dL
Females 4-32 ng/dL

 

Test Reference Range
Plasma Renin Activity 0.25-5.82 ng/mL/h
Aldosterone/PRA Ratio 0.9-28.9 Ratio
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS), Two-site immunoradiometric assays, chemiluminescence immunoassay, ELISA, radioimmunoassay.

Serum (SST), whole blood (EDTA).

Stability

  • Ambient: 8 hours
  • Refrigerated: 5 days
  • Frozen: 1 month
Angiotensin Converting Enzyme (ACE), Electrolyte Panel, Aldosterone, Renin activity.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login